作为抗菌和抗癌剂的Ugi衍生的类的设计和评估:实验和计算见解
Meenakshi1, Mettle Brahma2, Yangala Sudheer Babu2
1Department of Chemistry, School of Basic Sciences, Central University of Haryana, Mahendergarh, India.
Future medicinal chemistry
|November 4, 2025
概括
新型异环酸显示出双重抗菌和抗癌潜力,为抗耐药细菌和癌症的药物开发提供了新的途径. 这些化合物显示出显著的疗效,对正常细胞的毒性较低.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药物发现 药物发现 药物发现
背景情况:
- 多药性耐药性和当前治疗方法的局限性需要新的治疗药物.
- 异环化合物为开发具有双重抗菌和抗癌活性的药物提供了有希望的支架.
研究的目的:
- 合成具有潜在的双重抗菌和抗癌活性的新型N-异环.
- 评估合成的化合物与细菌菌株 (S. aureus,E. coli) 和癌细胞 (A549) 相对抗.
- 通过评估正常细胞 (Vero) 的细胞毒性来评估安全性.
主要方法:
- 使用Ugi多元组分反应合成N-异环类.
- 在体外评估抗菌和抗癌活性.
- 对正常细胞系的细胞毒性评估.
- 分子对接和分子动力学模拟以了解连接体-蛋白相互作用.
主要成果:
- 化合物5d对S. aureus和E. coli表现出显著的抗菌活性.
- 化合物5k和5l对A549细胞具有强大的抗癌效果,对Vero细胞的毒性最小.
- 分子对接揭示了对5a,5d和5l化合物的强烈结合亲和力,分子动力学证实了稳定的相互作用.
结论:
- 合成的Ugi衍生的类素具有显著的抗菌和抗癌特性.
- 这些peptoids的结构框架为未来的结构-活动关系研究提供了宝贵的见解.
- 这些发现支持N-异环的潜力,作为设计新疗法剂的基础.
相关概念视频
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...


